Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Trace Neuroscience has raised $101.0M in total funding. The most recent round was Series A. The last funding was announced in November 2024.
Trace Neuroscience's investors include RA Capital Management, Third Rock Ventures, Atlas Venture, GV.
Trace Neuroscience is headquartered in South San Francisco, United States.
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Trace Neuroscience is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trace Neuroscience — Funding & Investors." VCBacked, November 12, 2024, https://www.vcbacked.co/company/trace-neuroscience. Accessed July 19, 2026.
VCBacked. (2024). Trace Neuroscience — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/trace-neuroscience
{{cite web |title=Trace Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/trace-neuroscience |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated